Vimarsana
Biggest News Aggregation in the World

Page 33 - Genetic Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetic Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetic Technologies Today - Breaking & Trending Today

Biofortified tomatoes with edited genes to boost Vitamin D may be on sale soon - Vimarsana News

Biofortified tomatoes with edited genes to boost Vitamin D may be on sale soon

{"desktop":[{"injectionEnabled":false,"componentType":"gpt","targeting":{"index":-1,"hivis":"n"},"referenceNode":"header","hideOnSensitiveArticle":true,"hideOnFirstPageView":true,"relativePos":"after","name":"div-gpt-ad-oop-slot","isOOP":true,"type":"outOfPage"},{"componentType":"gpt","targeting":{"index":-2,"hivis":"n"},"referenceNode":&...

Applied Genetic Technologies: Fiscal Q3 Earnings Snapshot - Vimarsana News

Applied Genetic Technologies: Fiscal Q3 Earnings Snapshot

ALACHUA, Fla. (AP) _ Applied Genetic Technologies Corp. (AGTC) on Monday reported a loss...

Source: ctpost.com
TScan Therapeutics (NASDAQ:TCRX) versus Genetic Technologies (NASDAQ:GENE) Financial Analysis - Vimarsana News

TScan Therapeutics (NASDAQ:TCRX) versus Genetic Technologies (NASDAQ:GENE) Financial Analysis

TScan Therapeutics (NASDAQ:TCRX – Get Rating) and Genetic Technologies (NASDAQ:GENE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends. Analyst Ratings This is a summary of current recommendations […]

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript - Vimarsana News

Genetic Technologies Limited (GENE) CEO Simon Morriss on Q3 2022 Results - Earnings Call Transcript

Genetic Technologies Limited (NASDAQ:NASDAQ:GENE) Q3 2022 Earnings Conference Call April 20, 2022, 6:00 PM ET Company Participants Simon Morriss – Chief Executive Officer Mike Tonroe –...

Head-To-Head Survey: Applied Genetic Technologies (NASDAQ:AGTC) & TRACON Pharmaceuticals (NASDAQ:TCON) - Vimarsana News

Head-To-Head Survey: Applied Genetic Technologies (NASDAQ:AGTC) & TRACON Pharmaceuticals (NASDAQ:TCON)

Applied Genetic Technologies (NASDAQ:AGTC – Get Rating) and TRACON Pharmaceuticals (NASDAQ:TCON – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Earnings and Valuation This table compares Applied Genetic […]